结核与肺部疾病杂志 ›› 2021, Vol. 2 ›› Issue (1): 8-12.doi: 10.3969/j.issn.2096-8493.2021.01.003

• 专题笔谈 • 上一篇    下一篇

结核性脑膜炎脑脊液分子检测技术概述

韩利军(), 赵雪瑶   

  1. 130062 长春市传染病医院结核性脑膜炎诊断与治疗中心
  • 收稿日期:2021-02-10 出版日期:2021-03-30 发布日期:2021-03-24
  • 通信作者: 韩利军 E-mail:2301617255@qq.com
  • 基金资助:
    吉林省卫生与健康适宜技术推广项目(20208019)

Molecular detection technologies for diagnosing tuberculous meningitis using cerebrospinal fluid

HAN Li-jun(), ZHAO Xue-yao   

  1. Tuberculosis Meningitis Diagnosis and Treatment Center, Changchun Infection Hospital, Changchun 130062, China
  • Received:2021-02-10 Online:2021-03-30 Published:2021-03-24
  • Contact: HAN Li-jun E-mail:2301617255@qq.com

摘要:

结核性脑膜炎(tuberculous meningitis,TBM)是常见的中枢神经系统结核病,早期诊断和及时治疗是改善TBM患者预后的关键。由于传统的结核分枝杆菌检测方法阳性率低、耗时长,临床缺乏有效的快速检测手段,导致TBM的早期确诊非常困难。作者针对TBM脑脊液分子检测技术的现状、最新研究进展,以及所面临的问题进行评价和讨论,为指导结核病临床工作提供参考。

关键词: 结核, 脑膜, 脑脊髓液, 分子诊断技术

Abstract:

Tuberculous meningitis (TBM) is a common tuberculosis disease affecting central nervous system. Early diagnosis and timely treatment are key to improve the prognosis of TBM patients. However, traditional detection methods of MTB are usually with poor sensitivity and time-consuming, we lack effective rapid clinic detection methods, thus it is very difficult to make early diagnosis of TBM. In the review, the current situation, latest progress and existing problems of TBM molecular detecting technologies for testing cerebrospinal fluid samples were displayed and discussed, to offer references for clinical practice.

Key words: Tuberculosis, meningeal, Cerebrospinal fluid, Molecular diagnostic techniques